Wuxi Capital Group Co., Ltd.

Wuxi Capital Group Co., Ltd. is a state-owned venture capital institution that spans the entire investment life cycle—from seed, angel, and venture funding to growth equity, M&A, and secondary funds. Formerly known as Wuxi Financial Venture Investment Group, the company has evolved into a leading integrated investment platform.

Driven by a commitment to reform and innovation, Wuxi Capital Group continues to integrate resources and refine its investment system while exploring market-oriented mechanisms. It owns or controls several key investment management entities, including Jintou Capital, Guolian Industrial Investment, Guolian Capital, Huallywood Investment, and V-Capital. The firm also operates multiple mixed-ownership fund managers and maintains strategic offices in Beijing, Shanghai, Shenzhen, and Singapore. Backed by a seasoned and disciplined professional team, Wuxi Capital is steadily advancing toward its goal of becoming a globally influential venture capital group.

Wuxi Capital Group has established a fund system involving the entire lifecycle of companies and manages funds worth over 160 billion yuan. The company has invested in various sectors, including biomedicine, integrated circuits, dual-carbon energy conservation, high-end manufacturing, and artificial intelligence. Its portfolio includes companies such as Jianshi Medical, Jushu Biotechnology, Ruiyue Biotechnology, and Xiantong Pharmaceutical, contributing to the strengthening, supplementing, and extending of the biopharmaceutical industry chain in Wuxi.